Building Internal Healthcare Capability in the Gulf: A Workforce Perspective

Saudisation, Emiratisation, and their equivalents across GCC represent one of the most significant structural shifts in the regional healthcare workforce in a generation. For life sciences companies, this is not a compliance matter — it is a strategic opportunity.

What localisation means in practice

Saudi Vision 2030 targets significant increases in Saudi nationals employed across all healthcare sectors. In the UAE, Emiratisation quotas are expanding. For pharmaceutical and medical device companies, this means that partnerships, distributor relationships, and government engagement all increasingly require a demonstrated commitment to local talent development.

The capability gap

Our research across 40+ regional healthcare organisations identifies a consistent set of capability gaps: health economics and outcomes research, regulatory affairs, market access strategy, and clinical data management. These are exactly the disciplines that international life sciences companies bring — and they represent an opportunity to build structured knowledge transfer into commercial relationships.

How Biowave approaches this

We design and deliver training programmes in market access, HTA, regulatory strategy, and patient access for both local health authority staff and the teams of international companies operating in the region. These are not off-the-shelf programmes — they are built from first principles against the actual regulatory and reimbursement context of the target market.

Interested in building regional capability? Contact our training practice.